New

IDNAPTEX^® range

Ready-to-use dPCR assays

Simultaneous detection of mutations in cDNA and DNA

Optimized for

QIAcuity^® Digital PCR system

EASY TO USE

Ready-to-use mix of probes and primers.
Up to 23 targets in a single reaction

FAST

Results in
less than 4 hours

RELIABLE

Target controls included

PRECISE

ID SOLUTIONS
Patented technology*

OPTIMIZED

Universal amplification program
for all tests on QIAcuity^® Digital PCR system

A highly multiplexed solution

IDNAPTEX^® products accurately detect target mutations from plasma (cfDNA) or FFPE tissue (gDNA) using an innovative multiplexed solution.

Our tests are developed with optimised, ready-to-use primers and probes. This allows simultaneous amplification of multiple target mutations in a single well.

Accurate detection of mutations

Combined with assays from the IDNAPTEX range, the patented* ID-ICE reagent acts as an internal control, specially designed to assess the extraction efficiency of liquid biopsy samples.

This technology guarantees optimal monitoring of the entire pre-analytical process, reinforcing the reliability of the results obtained.

Universal amplification programme compatible with all tests

When used in conjunction with the QIAcuity digital PCR system, IDNAPTEX^® kits deliver results in less than three hours. This provides a fast, reliable and efficient solution for clinical oncology research.

A valued partner

As the exclusive partner for these products, QIAGEN is your dedicated source for information and support.

Visit the QIAGEN website or reach out to your local QIAGEN team today.

Explore our catalog of innovative digital PCR assays

IDNAPTEX^® H3F3A

Primers and Probes set for H3F3A mutations detection

IDNAPTEX^® BRAF-CNS

Primers and Probes set for BRAF mutations detection

IDNAPTEX^® EGFR SENSI

Primers and Probes set for EGFR mutations detection

IDNAPTEX^® EGFR RESIST

Primers and Probes set for EGFR mutations detection

IDNAPTEX^® KRAS G12C

Primers and Probes set for KRAS G12C mutation detection

IDNAPTEX^® KRAS 3X

Primers and Probes set for KRAS mutations detection on exon 2, 3 and 4

IDNAPTEX^® BRAF

Primers and Probes set for BRAF mutations detection

IDNAPTEX^® ESR1

Primers and Probes set for ESR1 mutations detection

IDNAPTEX^® TERT

Primers and Probes set for TERT mutations detection

IDNAPTEX^® FGFR1-CNS

Primers and Probes set for FGFR1 mutations detection and Exons 11 to 18 duplication detection

IDNAPTEX^® PIK3CA

Primers and Probes set for PIK3CA mutations detection

IDNAPTEX^® NRAS

Primers and Probes set for NRAS mutations detection

G12S, G12R, G12C, G12N, G12P, G12Y, G12D, G12A, G12V, G12E, G13S, G13R, G13C, G13N, G13Y, G13F, G13D, G13A, G13V, G60_Q61insAS, Q61E, Q61P, Q61R, Q61L, Q61H, Q61_E62>HK
Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
96 tests

IDNAPTEX^® IDH1-2

Primers and Probes set for IDH1 and IDH2 mutations detection

IDNAPTEX NRAS

Ensemble de sondes et d’amorces pour la détection des mutations NRAS

G12S, G12R, G12C, G12N, G12P, G12Y, G12D, G12A, G12V, G12E, G13S, G13R, G13C, G13N, G13Y, G13F, G13D, G13A, G13V, G60_Q61insAS, Q61E, Q61P, Q61R, Q61L, Q61H, Q61_E62>HK
ADN libre circulant (cfDNA) extrait à partir de plasma ou ADN génomique (gDNA) isolé à partir de tissus fixés en formol et inclus en paraffine (FFPE)
96 réactions

Associated products

ID-ICE

Internal control of extraction

IDNAPTEX EGFR RESIST

Système de distinction des mutations du gène BRAF dans le système nerveux central

^{*ID-ICE can be ordered separately. The patented ID SOLUTIONS technology is protected in Europe by patent number EP 3565902 and in the United States by patent number 12049664.}

^{QIAcuity is a registered trademark of QIAGEN. QIAcuity dPCR instruments, consumables, and tests are sold by QIAGEN under license from Bio-Rad Laboratories, Inc. for use on QIAcuity Digital PCR instruments and exclude rights for pediatric applications.}

^{QIAcuity is intended for molecular biology applications. This product is not intended for use in the diagnosis, prevention, or treatment of disease. Therefore, the performance characteristics of the product for clinical use (i.e., diagnostic, prognostic, therapeutic, or blood banking) are unknown.}

^{Trademarks: QIAGEN®, QIAcuity®. Registered names, trademarks, etc. used in this document, even if not specifically marked as such, may be protected by law.}

^{ID SOLUTIONS and IDNAPTEX are registered trademarks of ID SOLUTIONS.}

IDNAPTEX^® range

Ready-to-use dPCR assays

Simultaneous detection of mutations in cDNA and DNA